| JXSB2100003 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-01-06 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2022-01-20 | view |
| JXSB2000057 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-01-01 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2022-01-20 | view |
| JXSB2100007 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(3.1) | Supplementary Application | 2021-01-08 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2022-01-19 | view |
| JXSS2000051 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-11-23 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | Certificate Issued | 2021-09-03 | view |
| JXSB2000056 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | Merck Sharp & Dohme Corp. | Merck Sharp & Dohme Corp | In Review | 2021-05-09 | view |
| JXSB2100029 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-04-01 | | | In Review | 2021-03-31 | view |
| JXSB2100028 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-03-24 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-03-23 | view |
| JXSB2100022 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-03-16 | | | In Review | 2021-03-15 | view |
| JYSB2000618 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2020-12-14 | Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | Merck Sharp & Dohme Corp | Certificate Issued | 2021-03-12 | view |
| JXSL2100041 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-03-11 | | Merck Sharp & Dohme Corp | In Review | 2021-03-10 | view |
| JXSB2100017 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-03-02 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-03-01 | view |
| JXSB2100013 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-02-20 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-02-19 | view |
| JYSB2100036 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-01-28 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-01-27 | view |
| JXSS2000010 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Import Drug Application | 2020-05-01 | | | Certificate Issued | 2020-12-11 | view |
| JXSS2000063 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-12-14 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-12-11 | view |
| JXSL2000223 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-12-14 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-12-10 | view |
| JXSB2000040 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2020-12-03 | Merck Sharp & Dohme Corp. | Merck Sharp & Dohme Corp | In Review | 2020-12-02 | view |
| JXSB2000037 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2020-11-23 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-11-21 | view |
| JXSL2000196 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-11-04 | | Merck Sharp & Dohme Corp | In Review | 2020-11-03 | view |
| JXSL2000194 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-11-02 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2020-10-30 | view |
